The Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

A team of researchers has reported an important advance in the search for better treatments for advanced prostate cancer.

Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...

Stay connected via Google News Scientists at Umeå University in Sweden and partner institutions have developed an ...

The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty ...

A groundbreaking study published this July reveals that a targeted treatment for prostate cancer is just as effective as ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers said the test could improve early detection while reducing unnecessary follow-up procedures. Stockholm3 is still ...

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...

Key Takeaways The Stockholm3 blood test detects more prostate cancers than the standard PSA testThe test detects more ...

This large-scale, high-quality trial compares a promising alternative screening test to PSA. This may be the breakthrough for prostate cancer screening that we have all been waiting for,” said Kevin C ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...